Actively Recruiting

Phase Not Applicable
Age: 5Years - 17Years
All Genders
NCT07403084

Post-market Clinical Follow-up Study of NEMOST V2

Led by EUROS · Updated on 2026-02-11

140

Participants Needed

5

Research Sites

417 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children. As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino. Retrospective and prospective multicenter post-market surveillance clinical study. This study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The study will include 140 patients.

CONDITIONS

Official Title

Post-market Clinical Follow-up Study of NEMOST V2

Who Can Participate

Age: 5Years - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children aged 5 to 17 years with idiopathic, congenital, neuromuscular, or syndromic scoliosis
  • Progressive spinal deformity not controlled by orthopedic treatment and requiring primary surgery
  • Patient and parent or legal guardian are informed about participation in the study
  • Children must still have potential for growth
Not Eligible

You will not qualify if you...

  • Signs of local inflammation
  • Acute or chronic local or systemic infections
  • Non-reducible scoliosis
  • Pathological obesity
  • Allergy or intolerance to implanted materials
  • Insufficient or absent tissue coverage
  • Spine that has already been instrumented or fused

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Hopital Lenval Nice

Nice, Provence-Alpes-Côte d'Azur Region, France, 06000

Actively Recruiting

2

CHU Pellegrin

Bordeaux, France

Actively Recruiting

3

Hospices Civils de Lyon

Lyon, France

Not Yet Recruiting

4

Hopital Armand Trousseau

Paris, France

Not Yet Recruiting

5

Hopital Necker

Paris, France

Not Yet Recruiting

Loading map...

Research Team

C

Célia Armanet, PHD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here